Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Shorter course of PegIntron and Rebetol receives positive opinion in Europe

Aug. 2, 2005

HCV-I.E.T. studied in phase I/II trial for hepatitis C

Aug. 1, 2005

Valeant to develop Viramidine in Japan

Aug. 1, 2005

NDA accepted for filing for InKine's next-generation purgative product

Aug. 1, 2005

Phase Ib study examines GI-5005 for chronic HCV

July 29, 2005

Clinical trials support the use of certolizumab in active Crohn's disease

July 29, 2005

Zegerid Chewable Tablets NDA accepted for filing

July 28, 2005

Acambis' C. difficile vaccine begins phase I study

July 28, 2005

New agents for treating hepatitis C infection disclosed

July 27, 2005

Approvable letter for Entereg

July 26, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...